|
|
|
Insider
Information: |
Winningham Rick E |
Relationship: |
|
City: |
South San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
2,688,476 |
|
Indirect Shares
|
96,467 |
|
|
Direct
Value |
$31,541,999 |
|
|
Indirect Value
|
$896,178 |
|
|
Total
Shares |
2,784,943 |
|
|
Total
Value |
$32,438,177 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
0.0%
|
-15.1%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Innoviva Inc |
INVA |
Director |
2014-08-15 |
825,391 |
2008-01-29 |
0 |
Premium* |
|
Jazz Pharmaceuticals Inc |
JAZZ |
Director |
2023-08-14 |
10,444 |
2012-01-11 |
0 |
Premium* |
|
Theravance Biopharma, Inc. |
TBPH |
|
2024-05-15 |
1,852,641 |
2024-05-15 |
96,467 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
131 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
INVA |
Innoviva Inc |
Chief Executive Officer |
|
2010-08-20 |
4 |
D |
$14.00 |
$50,736 |
D/D |
(3,624) |
159,378 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2016-08-15 |
4 |
S |
$136.45 |
$86,373 |
D/D |
(633) |
15,391 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2013-08-13 |
4 |
S |
$81.86 |
$87,590 |
D/D |
(1,070) |
41,087 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2017-08-11 |
4 |
S |
$142.36 |
$94,248 |
D/D |
(662) |
11,094 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
CHIEF EXECUTIVE OFFICER |
|
2022-05-20 |
4 |
D |
$8.74 |
$96,359 |
D/D |
(11,025) |
1,440,588 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2019-08-09 |
4 |
S |
$135.65 |
$98,482 |
D/D |
(726) |
4,424 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2018-08-10 |
4 |
S |
$176.61 |
$116,563 |
D/D |
(660) |
4,950 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2020-08-07 |
4 |
S |
$125.87 |
$117,185 |
D/D |
(931) |
6,198 |
0 |
- |
|
INVA |
Innoviva Inc |
Chief Executive Officer |
|
2010-11-20 |
4 |
D |
$22.52 |
$125,099 |
D/D |
(5,555) |
181,323 |
0 |
- |
|
INVA |
Innoviva Inc |
Chief Executive Officer |
|
2011-11-20 |
4 |
D |
$22.34 |
$138,910 |
D/D |
(6,218) |
479,688 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2015-08-10 |
4 |
S |
$179.98 |
$144,178 |
D/D |
(801) |
14,659 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2014-08-12 |
4 |
S |
$133.15 |
$144,734 |
D/D |
(1,087) |
14,150 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
CHIEF EXECUTIVE OFFICER |
|
2022-08-19 |
4 |
D |
$9.34 |
$147,609 |
D/D |
(15,804) |
1,424,784 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
|
2019-11-20 |
4 |
D |
$17.60 |
$152,733 |
D/D |
(8,678) |
1,074,455 |
0 |
- |
|
INVA |
Innoviva Inc |
Chief Executive Officer |
|
2011-02-20 |
4 |
D |
$22.50 |
$152,775 |
D/D |
(6,790) |
422,033 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
CHIEF EXECUTIVE OFFICER |
|
2023-08-20 |
4 |
D |
$9.70 |
$153,299 |
D/D |
(15,804) |
1,611,769 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
|
2021-08-20 |
4 |
D |
$14.05 |
$160,226 |
D/D |
(11,404) |
1,313,414 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
CHIEF EXECUTIVE OFFICER |
|
2023-11-20 |
4 |
D |
$10.37 |
$163,887 |
D/D |
(15,804) |
1,595,965 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2022-08-08 |
4 |
S |
$152.32 |
$165,879 |
D/D |
(1,089) |
8,610 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2023-08-14 |
4 |
S |
$138.16 |
$171,455 |
D/D |
(1,241) |
10,444 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
CHIEF EXECUTIVE OFFICER |
|
2022-11-20 |
4 |
D |
$10.85 |
$171,473 |
D/D |
(15,804) |
1,409,797 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
|
2019-05-20 |
4 |
D |
$19.84 |
$172,172 |
D/D |
(8,678) |
1,091,811 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
CHIEF EXECUTIVE OFFICER |
|
2023-05-20 |
4 |
D |
$11.21 |
$177,163 |
D/D |
(15,804) |
1,627,573 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
|
2019-08-20 |
4 |
D |
$21.51 |
$186,664 |
D/D |
(8,678) |
1,083,133 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2021-08-06 |
4 |
S |
$147.96 |
$193,236 |
D/D |
(1,306) |
7,138 |
0 |
- |
|
131 Records found
|
|
Page 3 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|